A novel radiation treatment for cancer that targets tumors from the inside using alpha particles is now in Phase 3 pivotal trials ahead of receiving Food and Drug Administration (FDA) approval.
Read more here.
A novel radiation treatment for cancer that targets tumors from the inside using alpha particles is now in Phase 3 pivotal trials ahead of receiving Food and Drug Administration (FDA) approval.
Read more here.
![[CropX in PR Newswire] ICL Invests in CropX, Makes First Investment in Precision Ag](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
